Filter
2096
Text search:
Antiretroviral
Drugs
Featured
Recommendations
180
New Publications
578
Language
Document type
No document type
1445
Guidelines
257
Studies & Reports
226
Manuals
49
Strategic & Response Plan
38
Training Material
30
Fact sheets
27
Situation Updates
10
Infographics
10
Online Courses
2
Resource Platforms
1
Countries / Regions
India
77
Kenya
71
South Africa
69
Zambia
58
Tanzania
56
Ethiopia
47
Malawi
46
Global
46
Nigeria
45
Uganda
38
Nepal
37
Western and Central Europe
35
Rwanda
32
Namibia
32
Liberia
31
Africa
31
Ukraine
28
Lesotho
28
Eastern Europe
28
Myanmar / Burma
27
Ghana
26
Sierra Leone
25
Zimbabwe
24
Asia
24
Latin America and the Carribbean
19
Indonesia
17
Cambodia
16
Botswana
16
Russia
16
Bangladesh
15
Mozambique
15
Philippines
13
South–East Asia Region
12
Senegal
11
Burkina Faso
10
Eswatini/ Swaziland
10
Congo, Democratic Republic of
7
Cameroon
7
East and Southern Africa
7
Venezuela
7
Tajikistan
7
Argentina
6
Albania
6
Haiti
5
Pakistan
5
Benin
5
Colombia
5
Georgia
5
Guinea
4
North Macedonia
4
Syria
3
Brazil
3
West and Central Africa
3
Paraguay
3
Armenia
3
Vietnam
3
Somalia
2
South Sudan
2
Afghanistan
2
Germany
2
Thailand
2
Bolivia
2
Yemen
2
Middle East and North Africa
2
Western Pacific Region
2
Eastern Europe and Central Asia
2
Estonia
2
Romania
2
Moldova
2
Mali
1
Guinea-Bissau
1
Côte d’Ivoire / Ivory Coast
1
Saudi Arabia
1
Niger
1
Iraq
1
Jordan
1
Lebanon
1
Egypt
1
Gambia
1
China
1
Papua New Guinea
1
Sudan
1
Central African Republic
1
Peru
1
Serbia
1
Hungary
1
Burundi
1
Libya
1
Angola
1
Sri Lanka
1
Chile
1
Bhutan
1
Poland
1
Palestine
1
Djibouti
1
Southern Africa
1
Laos
1
Canada
1
Qatar
1
Bulgaria
1
Iran
1
North America
1
Turkmenistan
1
Jamaica
1
Authors & Publishers
Publication Years
Category
Countries
827
Clinical Guidelines
179
Women & Child Health
89
Public Health
59
Capacity Building
47
Key Resources
44
Pharmacy & Technologies
21
Annual Report MEDBOX
1
Toolboxes
HIV
680
TB
265
Pharmacy
46
COVID-19
41
Mental Health
38
Caregiver
33
AMR
25
Refugee
22
Conflict
19
Health Financing Toolbox
17
Ebola & Marburg
14
Global Health Education
14
NTDs
14
NCDs
13
Disability
12
Natural Hazards
8
Polio
7
Social Ethics
4
Malaria
4
Rapid Response
3
Zika
1
Planetary Health
1
2.0 Rapid Response
1
Results and Lessons Learned from CapacityPlus 2009-2015
Antimicrobial resistance (AMR) is a global public health crisis that resulted in 1.14 million deaths in 2021. According to the Institute for Health Metrics and Evaluation estimates, 96 416 of these deaths occurred in the World Health Organization (WHO) Eastern Mediterranean Region. All 22 countr
...
Data from the 2011 Ethiopia Demographic and Health Survey
Significant progress has been made in the eradication of three priority diseases in the African Region, as a result of extensive collaboration between the Regional Office, WHO country offices and countries. For example, in August 2020, the region was certified free of wild poliovirus. In the area of
...
Reporting Period 2010-2011
In Tanzania, institutional efforts to combat HIV/AIDS started in 1985 by establishing a National Taskforce within the Ministry of Health. This was so because the HIV/AIDS epidemic was first perceived as a health problem, and the initial control efforts were formulated and based within the health sec
...
Tuberculosis cases, TB deaths
This paper presents a bibliometric analysis of the literature on private health aid and official health assistance between 2000 and 2022. It provides an overview of the sites and themes in the literature pertaining to development assistance in health, and collates the significant policy recommendati
...
Tuberculosis (TB) is among the top ten most common causes of death globally and as a single infectious disease it top among infectious diseases. Furthermore, it is noted as the top causes of death among people infected with the human immunodeficiency virus (HIV). Despite recent decreases in the numb
...
A historic funding crisis is threatening to unravel decades of progress unless countries can make radical shifts to HIV programming and funding. The report highlights the impact that the sudden, large-scale funding cuts from international donors are having on countries most affected by HIV. Yet it a
...
A historic funding crisis is threatening to unravel decades of progress unless countries can make radical shifts to HIV programming and funding. The report highlights the impact that the sudden, large-scale funding cuts from international donors are having on countries most affected by HIV. Yet it a
...
Offering additional pre-exposure prophylaxis (PrEP) choices has the potential to increase uptake and effective use of PrEP, and of HIV prevention overall, as it allows people to choose a method that they prefer.
In this guideline, WHO recommends an offering long-acting injectable lenacapavir (LEN
...
Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. Web Annex B
